OVERALL AND CANCER-SPECIFIC SURVIVAL OF HIGH-RISK PROSTATE CANCER - IMPACT OF ADJUVANT THERAPY AFTER RADICAL PROSTATECTOMY

被引：0
|
作者：
Ganev, Tosho [1 ,2 ]
机构：
[1] Med Univ Varna, Fac Med, Dept Surg, MHAT Sveta Anna,Clin Urol, Varna, Bulgaria
[2] Med Univ Varna, Dept Surg, Clin Urol, MHAT Sveta Anna Varna, 100 Tzar Osvoboditel Blvd, Varna 9000, Bulgaria
来源：
JOURNAL OF IMAB | 2023年 / 29卷 / 04期
关键词：
hormonal therapy; radiotherapy; Gleason score; MULTIMODAL TREATMENT; SCORE;
D O I：
10.5272/jimab.2023294.5188
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Purpose: The study examines the survival of patients with high-risk prostate cancer in order to find a relationship between survival and the type of postoperative therapy.Materials/Methods: The object of the study were 872 patients who underwent radical prostatectomy in the Clinic of Urology in "St. Anna Varna" Hospital for the period from April 17, 1996, until November 25, 2022. Postoperatively, some patients were additionally subjected to hormonal therapy (referred to as "dual therapy" in the text), and others to hormonal and radiotherapy (referred to as "triple therapy").Results: Overall and cancer-specific survival of high risk patients did not differ statistically significantly for the two types of postoperative therapy.Conclusions: The optimal combination of radical prostatectomy, hormonal and radiotherapy in order to achieve maximum survival for patients with high-risk prostate cancer is still poorly defined.
引用
收藏
页码：5188 / 5191
页数：4
相关论文
共 50 条
  • [21] Adjuvant Androgen Deprivation for High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921 Study
    Dorff, Tanya B.
    Flaig, Thomas W.
    Tangen, Catherine M.
    Hussain, Maha H. A.
    Swanson, Gregory P.
    Wood, David P., Jr.
    Sakr, Wael A.
    Dawson, Nancy A.
    Haas, Naomi B.
    Crawford, E. David
    Vogelzang, Nicholas J.
    Thompson, Ian M.
    Glode, L. Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15) : 2040 - 2045
  • [22] Radical Prostatectomy is a Valuable Treatment Alternative in Patients with High-Risk Prostate Cancer
    Mangir, Naside
    Top, Tuncay
    Tinay, Ilker
    Tanidir, Yiloren
    Turkeri, Levent
    JOURNAL OF UROLOGICAL SURGERY, 2015, 2 (03): : 124 - 128
  • [23] Predictive factors of biochemical recurrence after radical prostatectomy for high-risk prostate cancer
    Murata, Yukiko
    Tatsugami, Katsunori
    Yoshikawa, Masahiro
    Hamaguchi, Masumitsu
    Yamada, Shigetomo
    Hayakawa, Yusuke
    Ueda, Kouhei
    Momosaki, Seiya
    Sakamoto, Naotaka
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 (03) : 284 - 289
  • [24] Radiotherapy before and after radical prostatectomy for high-risk and locally advanced prostate cancer
    Perez, Bradford A.
    Koontz, Bridget F.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (05) : 226 - 234
  • [25] NADiA ProsVue Prostate-specific Antigen Slope, CAPRA-S, and Prostate Cancer-specific Survival After Radical Prostatectomy
    Moul, Judd W.
    Sarno, Mark J.
    McDermed, Jonathan E.
    Triebell, Melissa T.
    Reynolds, Mark A.
    UROLOGY, 2014, 84 (06) : 1427 - 1432
  • [26] Impact of percent positive biopsy cores on cancer-specific mortality for patients with high-risk prostate cancer
    Yang, David D.
    Muralidhar, Vinayak
    Mahal, Brandon A.
    Vastola, Marie E.
    Boldbaatar, Ninjin
    Labe, Shelby A.
    Nezolosky, Michelle D.
    Martin, Neil E.
    King, Martin T.
    Mouw, Kent W.
    Choueiri, Toni K.
    Trinh, Quoc-Dien
    Nguyen, Paul L.
    Orio, Peter F., III
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (09) : 735.e9 - 735.e15
  • [27] Adjuvant hormone therapy after radical prostatectomy in high-risk localized and locally advanced prostate cancer: First multicenter, observational study in China
    Ye, Dingwei
    Zhang, Wei
    Ma, Lulin
    Du, Chuanjun
    Xie, Liping
    Huang, Yiran
    Wei, Qiang
    Ye, Zhangqun
    Na, Yanqun
    CHINESE JOURNAL OF CANCER RESEARCH, 2019, 31 (03) : 511 - 520
  • [28] Re: Adjuvant Androgen Deprivation for High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921 Study
    Rozet, Francois
    Mongiat-Artus, Pierre
    EUROPEAN UROLOGY, 2011, 60 (03) : 598 - 599
  • [29] Re: Adjuvant Androgen Deprivation for High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921 Study
    Joniau, Steven
    Spahn, Martin
    EUROPEAN UROLOGY, 2011, 60 (05) : 1121 - 1122
  • [30] Prostate Cancer-Specific Mortality After Radical Prostatectomy for Patients Treated in the Prostate-Specific Antigen Era
    Stephenson, Andrew J.
    Kattan, Michael W.
    Eastham, James A.
    Bianco, Fernando J., Jr.
    Yossepowitch, Ofer
    Vickers, Andrew J.
    Klein, Eric A.
    Wood, David P.
    Scardino, Peter T.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (26) : 4300 - 4305
12345